EUVIMED · CrossrefZeitschrift
ImmunoMedicine
ISSN 2510-5345 · Wiley
Neueste Artikel
The cross‐disciplinary intellectual stream of ImmunoMedicine
My new normal: A patient's perspective on polymyalgia rheumatica
Simply Science : The Eighth Annual Bone Marrow Transplant and Cell Therapy Workshop (Orlando, Florida, USA)
Next Generation Therapeutic Strateg‐Es: Evolving cancer immunotherapy through agents that Engage , Expand and Enable the anti‐tumor immune response
Neoantigen‐based vaccines as a promising strategy in cancer immunotherapeutics
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Issue Information
Issue Information
Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)
Vaccination for cancer: Myth or reality
Comprehensive approach for identification of functional FCGR2C alleles resulting in protein expression as a determinant for predicting predisposition to autoimmunity
Understanding immunotherapy terminology: An analysis of provider‐patient conversations
The effects of tumor‐derived exosomes on T‐cell function and efficacy of cancer immunotherapy
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
HLA‐matched allogeneic anti‐CD19 CAR‐T therapy in treating a relapsed/refractory acute lymphoblastic leukemia patient with high tumor burden
Comparing VIP and PD‐L1 expression as cancer biomarkers
Infections in hematologic malignancy patients treated by CD19 chimeric antigen receptor T‐cell therapy
CAR T cell therapy in advanced B‐ALL with heavy disease burden
Special issue: CAR‐T cell therapy for hematological malignancies
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Issue Information
Metabolic inhibitor screening identifies dihydrofolate reductase as an inducer of the tumor immune escape mediator CD24
Programmed death‐ligand 1 expression in Epstein‐Barr virus positive nasopharyngeal cancer
Issue Information
Purinergic signaling and purine base metabolism at the crossroads between immunity, metabolism, and cancer: A review
Issue Information
Issue Information
The use of transcriptomic data in developing biomarkers in breast cancer
Engineered immunologic niche monitors checkpoint blockade response and probes mechanisms of resistance
EUVIMED